New Analyst Coverage
Published on Tuesday, 18 September 2012 07:55 Written by Danny Miller
New York, September 18th (TradersHuddle.com) – Following are some of the new analyst ratings before the market open.
Research Firms Initiate:
Allergan (NYSE: AGN) was initiated with a Buy and a target price of $102 at Guggenheim.
Bloomin' Brands (NASDAQ: BLMN) was initiated with a Hold at Deutsche Bank.
Carbo Ceramics (NYSE: CRR) was initiated with a Market Perform at William Blair.
Dover (NYSE: DOV) was initiated with a Neutral at Citigroup.
HeartWare International (NASDAQ: HTWR) was initiated with a Buy and a target price of $112 at WallachBeth.
Jazz Pharmaceuticals (NASDAQ: JAZZ) was initiated with a Buy and a target price of $60 at Guggenheim.
Mylan (NASDAQ: MYL) was initiated with a Neutral and a target price of $26 at Guggenheim.
Teva Pharmaceuticals (NYSE: TEVA) was initiated with a Neutral and a target price of $45 at Guggenheim.
Watson Pharmaceuticals (NYSE: WPI) was initiated with a Buy and a target price of $100 at Guggenheim.
- AT&T And America Movil To Provide Deeper National Reach For Advanced Enterprise Services Across Latin America
- AT&T 4G LTE Available In Willimantic
- AT&T 4G LTE Available In Torrington
- AT&T And The University Of Kansas Team Up To Enhance Wireless Coverage On Lawrence Campus
- AT&T 4G LTE Available In Fargo
- AT&T 4G LTE Available In Amarillo
- Benefitfocus Announces Pricing of Initial Public Offering
- Trends of China Gear Industry 2013 Analysis & Reviewed in New Research Report at RnRMarketResearch.com
- Product Launch Formula 4.0 Bonuses Total $5000 at BrianHanson.com
- Datex Presents Motorola Solutions Webinar “Is It ‘Smart’ to Use Smartphones for the Enterprise?”
Related Partner Headlines
Recent Trading Ideas
Latest Partner Headlines